title: α₁A-adrenergic receptors regulate cardiac hypertrophy in vivo through interleukin-6 secretion.
abstract: The role of α₁-adrenergic receptors (ARs) in the regulation of cardiac hypertrophy is still unclear, because transgenic mice demonstrated hypertrophy or the lack of it despite high receptor overexpression. To further address the role of the α₁-ARs in cardiac hypertrophy, we analyzed unique transgenic mice that overexpress constitutively active mutation (CAM) α₁A-ARs or CAM α₁B-ARs under the regulation of large fragments of their native promoters. These constitutively active receptors are expressed in all tissues that endogenously express their wild-type counterparts as opposed to only myocyte-targeted transgenic mice. In this study, we discovered that CAM α₁A-AR mice in vivo have cardiac hypertrophy independent of changes in blood pressure, corroborating earlier studies, but in contrast to myocyte-targeted α₁A-AR mice. We also found cardiac hypertrophy in CAM α₁B-AR mice, in agreement with previous studies, but hypertrophy only developed in older mice. We also discovered unique α₁-AR-mediated hypertrophic signaling that was AR subtype-specific with CAM α₁A-AR mice secreting atrial naturietic factor and interleukin-6 (IL-6), whereas CAM α₁B-AR mice expressed activated nuclear factor-κB (NF-κB). These particular hypertrophic signals were blocked when the other AR subtype was coactivated. We also discovered that crossbreeding the two CAM models (double CAM α₁A/B-AR) inhibited the development of hypertrophy and was reversible with single receptor activation, suggesting that coactivation of the receptors can lead to novel antagonistic signal transduction. This was confirmed by demonstrating antagonistic signals that were even lower than normal controls in the double CAM α₁A/B-AR mice for p38, NF-κB, and the IL-6/glycoprotein 130/signal transducer and activator of transcription 3 pathway. Because α₁A/B double knockout mice fail to develop hypertrophy in response to IL-6, our results suggest that IL-6 is a major mediator of α₁A-AR cardiac hypertrophy.
authors: Department of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
authors: Robert S
authors: RS
authors: Papay
authors: Ting
authors: T
authors: Shi
authors: Michael T
authors: MT
authors: Piascik
authors: Sathyamangla V
authors: SV
authors: Naga Prasad
authors: Dianne M
authors: DM
authors: Perez
mesh_terms: D000818:Animals; D006332:Cardiomegaly / Q000378:metabolism*; D015850:Interleukin-6 / Q000378:metabolism*; D051379:Mice; D018345:Mice, Knockout; D008822:Mice, Transgenic; D032383:Myocytes, Cardiac / Q000378:metabolism; D016328:NF-kappa B / Q000378:metabolism; D018340:Receptors, Adrenergic, alpha-1 / Q000378:metabolism*; D015398:Signal Transduction; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism
chemical_list: D015850:Interleukin-6; D016328:NF-kappa B; D018340:Receptors, Adrenergic, alpha-1; D048051:p38 Mitogen-Activated Protein Kinases
references: J Biol Chem. 2012 Jan 20;287(4):2666-77
references: 22157761
references: J Biol Chem. 1996 Mar 8;271(10):5839-43
references: 8621454
references: Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):10109-13
references: 7937846
references: FEBS Lett. 1996 May 20;386(2-3):141-8
references: 8647269
references: Mol Pharmacol. 2003 May;63(5):1104-16
references: 12695539
references: Cardiovasc Res. 2003 Feb;57(2):443-55
references: 12566117
references: Mol Pharmacol. 2006 Jan;69(1):45-55
references: 16195468
references: J Auton Pharmacol. 2000 Oct-Dec;20(5-6):305-12
references: 11350496
references: J Mol Cell Cardiol. 2011 Oct;51(4):518-28
references: 21118696
references: Mol Pharmacol. 1991 Dec;40(6):876-83
references: 1661838
references: Am J Physiol Heart Circ Physiol. 2001 Aug;281(2):H931-8
references: 11454600
references: J Biol Chem. 2000 Jan 21;275(3):2087-97
references: 10636913
references: J Recept Signal Transduct Res. 2011 Apr;31(2):98-110
references: 21338248
references: J Pharmacol Exp Ther. 2011 Aug;338(2):648-57
references: 21571945
references: Cardiovasc Res. 2005 Feb 1;65(2):436-45
references: 15639483
references: Circ Res. 2001 Aug 17;89(4):343-50
references: 11509451
references: Am J Physiol Heart Circ Physiol. 2006 Aug;291(2):H797-803
references: 16565302
references: Mol Pharmacol. 2009 Jul;76(1):144-52
references: 19363165
references: Mol Pharmacol. 1994 Nov;46(5):823-31
references: 7969068
references: Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):315-9
references: 10618415
references: J Clin Invest. 2006 Apr;116(4):1005-15
references: 16585965
references: Biochim Biophys Acta. 2005 Aug 1;1714(1):56-62
references: 16036214
references: Circ Res. 2004 Jul 23;95(2):187-95
references: 15192020
references: Naunyn Schmiedebergs Arch Pharmacol. 1994 Aug;350(2):136-42
references: 7990970
references: Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11589-94
references: 9326654
references: Naunyn Schmiedebergs Arch Pharmacol. 2010 Dec;382(5-6):475-82
references: 20857090
references: Mol Pharmacol. 2001 May;59(5):1225-34
references: 11306707
references: Mol Cell Biol. 1998 Jun;18(6):3518-26
references: 9584192
references: Proc Natl Acad Sci U S A. 1995 May 23;92(11):4862-6
references: 7539136
references: J Cell Biol. 1997 Oct 6;139(1):115-27
references: 9314533
references: Curr Mol Med. 2009 Sep;9(7):814-25
references: 19860661
references: Am J Physiol. 1998 Oct;275(4):H1338-50
references: 9746484
references: Br J Pharmacol. 1994 Feb;111(2):533-8
references: 7911718
references: Proc Natl Acad Sci U S A. 1988 Oct;85(19):7159-63
references: 2845398
references: Am J Physiol Heart Circ Physiol. 2000 Sep;279(3):H1079-86
references: 10993770
references: Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12929-34
references: 14566054
references: J Clin Invest. 1983 Aug;72(2):732-8
references: 6135712
references: Mol Pharmacol. 2003 Dec;64(6):1317-24
references: 14645661
references: Circulation. 2002 Jan 29;105(4):509-15
references: 11815436
references: Mol Pharmacol. 1999 Dec;56(6):1288-97
references: 10570057
references: J Biol Chem. 2003 Oct 10;278(41):40239-51
references: 12888550
references: Nature. 1999 Jun 17;399(6737):697-700
references: 10385123
references: J Biol Chem. 2011 Nov 11;286(45):39623-31
references: 21940628
references: J Mol Cell Cardiol. 1998 Aug;30(8):1515-23
references: 9737938
references: Circulation. 1995 Mar 1;91(5):1520-4
references: 7867193
references: J Recept Signal Transduct Res. 2012 Apr;32(2):76-86
references: 22268811
references: J Cell Biol. 1998 Jul 27;142(2):523-35
references: 9679149
references: Cardiovasc Res. 2004 Aug 15;63(3):373-80
references: 15276462
references: Am J Cardiol. 1973 Sep 20;32(4):398-406
references: 4269697
references: J Pharmacol Exp Ther. 2001 Aug;298(2):441-52
references: 11454904
references: Cell Physiol Biochem. 2009;23(4-6):327-34
references: 19471100
references: J Biol Chem. 2000 Aug 4;275(31):23814-24
references: 10781614
references: J Biol Chem. 2001 Apr 27;276(17):13738-43
references: 11278430
references: Circulation. 1996 Nov 15;94(10):2626-32
references: 8921810
references: J Clin Invest. 1990 Mar;85(3):731-8
references: 2312724
references: Nat Med. 2000 Dec;6(12):1388-94
references: 11100125
references: J Biol Chem. 1993 Jul 25;268(21):15374-80
references: 8393439